Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Saxenda is an injectable weight loss pen that contains the active ingredient liraglutide
Heres what the clinical evidence shows: Study Scope: 900+ participants across 6 randomized, double-blind, placebo-controlled trials Safety Profile: Indistinguishable from placebo in tolerability assessments Serious Events: Zero serious adverse events attributed to AOD-9604 Withdrawals: No treatment-related discontinuations in any trial Common Effects: Mild headache and minor GI symptoms at rates similar to placebo IGF-1 Impact: No effect on insulin-like growth factor-1 levels Metabolic Safety: No negative impact on glucose metabolism or insulin sensitivity Immunogenicity: Zero participants developed anti-AOD9604 antibodies The following analysis provides complete details on the clinical trial evidence supporting AOD-9604s favorable safety profile
Athletes and Active Individuals Runners, CrossFitters, recreational athletes, and fitness enthusiasts seeking faster recovery from injury, reduced downtime after intense training, support for chronic overuse injuries (tendinopathies, muscle tears), and a potential edge in the healing process
The constant loading from daily activities makes complete rest nearly impossible
Protein-forward, whole-food diets with a modest caloric deficit, combined with resistance training and adequate sleep, drive the same lipolysis pathways that AOD-9604 targets pharmacologically
This is a prescription only medication so you should run any dose queries past your prescribing vet
